AllianceBernstein
KERX

AllianceBernstein’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

AllianceBernstein’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-75,000
Closed -$533K – 3117
2017
Q3 		$533K Buy
+75,000
New +$539K ﹤0.01% 2543

AllianceBernstein's KERX Position: Q4 2018 in Review

AllianceBernstein sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 162,790 shares — an estimated $553K sold.

AllianceBernstein first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $2.8M in Q2 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • AllianceBernstein reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • AllianceBernstein sold 162,790 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $553K.
  • AllianceBernstein first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
  • AllianceBernstein's Keryx Biopharmaceuticals Inc position peaked at $2.8M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on AllianceBernstein's 13F filing for Q4 2018, filed 13 Feb 2019.